Northwestern Mutual Wealth Management Co. decreased its holdings in shares of VanEck Biotech ETF (NASDAQ:BBH – Get Rating) by 29.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 511 shares of the company’s stock after selling 209 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in VanEck Biotech ETF were worth $83,000 at the end of the most recent quarter.
Other institutional investors also recently modified their holdings of the company. Retirement Planning Co of New England Inc. acquired a new stake in shares of VanEck Biotech ETF during the 4th quarter worth approximately $28,000. Tyler Stone Wealth Management acquired a new stake in shares of VanEck Biotech ETF during the 4th quarter worth approximately $155,000. UMB Bank N A MO acquired a new stake in shares of VanEck Biotech ETF during the 4th quarter worth approximately $170,000. Nauset Wealth Management. LLC acquired a new stake in shares of VanEck Biotech ETF during the 1st quarter worth approximately $166,000. Finally, Howard Wealth Management LLC grew its holdings in VanEck Biotech ETF by 20.8% during the first quarter. Howard Wealth Management LLC now owns 1,368 shares of the company’s stock valued at $221,000 after purchasing an additional 236 shares during the period. Institutional investors and hedge funds own 29.91% of the company’s stock.
VanEck Biotech ETF Stock Performance
Shares of NASDAQ BBH opened at $147.96 on Friday. The firm has a 50 day moving average price of $152.88 and a 200 day moving average price of $152.78. VanEck Biotech ETF has a 52-week low of $131.12 and a 52-week high of $220.01.
VanEck Biotech ETF Profile
The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.
Receive News & Ratings for VanEck Biotech ETF Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for VanEck Biotech ETF and related companies with MarketBeat.com’s FREE daily email newsletter.